Digital health strategy and innovation consulting

We help pharma companies to define their digital health strategy, with a focus on transforming patient experiences and outcomes within their therapeutic area of interest.

Our team have the in-depth expertise and experience to help with:

Business opportunity and strategy development
User research and insights
Solution ideation, clinical pathway and service design
Regulatory, technology, and reimbursement strategy
Find out more
Our end-to-end process
We partner with pharma companies to seamlessly take them from product definition and creation, through to commercialization of digital health solutions that fit corporate and brand commercial strategies.
big-1-3 Align & Define i
big-2 Create & Validate i
big-3 Operate & Evolve i
Groupe 766
Discover
i
Groupe 860
Diagnose
i
Groupe 797
Ideate
i
Groupe 812
Specify
i
Groupe 779
Co-create
i
Vlidate
Validate
i
Groupe 1189
Registration
i
Groupe 871
Roll-out
i
Support
Support
i
Groupe 834
Monitor
i
Groupe 849
Evolve
i
We have delivered ...
20+ Regulated medical devices
View

Regulated medical devices

Quality Management (ISO 13485, 21 CFR 820)

Information Security for Managed Services (ISO 27001)

Medical Device Risk Management (ISO 14971)

Medical Device Software (ISO 63204)

Medical Device Usability (IEC 62366)

Regulation 2017/745 on Medical Devices (MDR)

Directive 93/42/EEC concerning Medical Devices (MDD)

Medical Device Cybersecurity (UL 2900, TIR 57)

20+ Across 20+ therapy areas
View

Across 20+ therapy areas

Endocrinology
Type 2 diabetes
Type 1 diabetes
Gestational diabetes

Immunology
Rheumatoid Arthritis
Crohn’s disease
Psoriasis
Psoriatic Arthritis
Ulcerative Colitis
Systemic Lupus Erythematosus

Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Non-Hodgkin’s Lymphoma

Respiratory
COPD
Asthma
Sleep Apnoea
Hypoxic Respiratory Failure

Cardiology
Congestive Heart Failure
Stroke
Atrial Fibrillation

Central Nervous System
Multiple Sclerosis

Neurology
Spinal Muscular Atrophy
Epilepsy

Musculoskeletal
Rare Disease – Osteochondrodysplasic

50+ In over 50 countries
View

In over 50 countries

Europe
Austria
Belgium
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Italy
Latvia
Lithuania
Luxembourg
Netherlands
Poland
Portugal
Slovakia
Spain
Sweden
Switzerland
Turkey
United Kingdom

Americas
Argentina
Canada
Chile
Colombia
Ecuador
Mexico
Peru
United States
Venezuela

APAC
Australia
Hong Kong
Korea
Macau
Malaysia
Taiwan
Thailand
Africa

Morocco
Tunisia
South Africa

Middle East
Egypt
Israel
Kuwait
Lebanon
Qatar
Saudi Arabia
United Arab Emirates

Certifications and regulatory compliance
BSI-Assurance-Mark-ISO-13485
BSI-Assurance-Mark-ISO-27001
HIPAA
GDPR

Our pharma partners

Rare Diseases - Digital Patient Support Program across multiple territories

Rare Diseases - Digital Patient Support Program across multiple territories

Download our Case Study to learn how S3 Connected Health played a key role in the design, development and delivery of the mobile and web-based system for MSdialog, a digital patient support program designed to give Multiple Sclerosis (MS) patients control over the management of their disease.

 

Download Case Study
Lilly
Biogen
Pfizer
MDS
Janssen
Otsuka